Independent and joint cross-sectional associations of statin and metformin use with mammographic breast density.
Erica J Lee ArgovTeofilia AcheampongMary Beth TerryCarmen B RodriguezMariangela AgovinoYing WeiShweta AthilatParisa TehranifarPublished in: Breast cancer research : BCR (2020)
Statin use was consistently associated with lower MBD, measured both through clinical radiologist assessment and continuous relative and absolute measures, including dense area. Metformin use was associated with lower PD and higher NDA, but this may be driven by co-medication with statins. These results support that statins may lower MBD but need confirmation with prospective and clinical data to distinguish the results of medication use from that of disease.